Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine
Clinical trial NCT01443663 · COMPLETED
Trial details
- NCT number
- NCT01443663
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2012-09-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.